Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2421
Dr. Dunavin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- Ohio State University HospitalResidency, Internal Medicine, 2009 - 2012
- University of Kansas School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2019 - 2027
- MD State Medical License 2015 - 2022
- KS State Medical License 2016 - 2020
- OH State Medical License 2009 - 2017
- DC State Medical License 2013 - 2014
- American Board of Internal Medicine Hematology
Clinical Trials
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia Start of enrollment: 2012 Jun 06
Publications & Presentations
PubMed
- A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care.Vanessa E Kennedy, Roberto Ruiz-Cordero, Diwash Jangam, Kwun Wah Wen, Neil Dunavin
Clinical Lymphoma, Myeloma & Leukemia. 2021-07-01 - 49 citationsWJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1Meizhang Li, Rupal Soder, Sunil Abhyankar, Haitham Abdelhakim, Mitchell W. Braun
Journal of Extracellular Vesicles. 2021-02-01 - 24 citationsA Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Ver...Rupal Soder, Buddhadeb Dawn, Mark L. Weiss, Neil Dunavin, Scott Weir
Stem Cell Reviews and Reports. 2020-10-01
Press Mentions
- Emerging Agents, Treatment Selection Criteria Key to Improving Outcomes in MyelofibrosisJanuary 20th, 2020
- Dr. Dunavin on Treatment Considerations in MyelofibrosisJanuary 10th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
